dj Orthopedics to Release Fourth Quarter and Year End 2003 Results on January 28, 2004 and Company to Present at the 16th Annual Piper Jaffray Healthcare Conference on January 29, 2004
Live Webcast Provided for Both Events
SAN DIEGO, Jan. 16 /PRNewswire-FirstCall/ -- dj Orthopedics, Inc., (NYSE: DJO), a designer, manufacturer and marketer of products and services for the orthopedic sports medicine market, today announced the following information for the release of its fourth quarter 2003 financial results and a conference call to discuss those results.
Earnings Date: Wednesday, January 28, 2004
Time: Financial Results: 1:05 PM Pacific Time, 4:05 PM Eastern Time
Conference Call: 2:00 PM Pacific Time, 5:00 PM Eastern Time
Dial In: -0177 using the reservation code 5034054. The Company recommends dialing in 5 to 10 minutes prior to scheduled start time.
Replay: -9291 for all callers. Enter reservation code 5034054. Replay ends 48 hours after call.
Live Internet: www.djortho.com , accessed through the Investor Relations portion of the Company's website. The webcast will be archived following the completion of the call.
The Company also announced that it has been invited to make a presentation to investors at the 16th Annual Piper Jaffray Healthcare Conference, held at the Pierre Hotel in New York City. The Company's presentation will focus on its strategy and position within its markets. All interested investors may listen to the presentation live via webcast beginning at 7:00 AM Pacific Time, 10:00 AM Eastern Time, on Thursday, January 29, 2004, by visiting the Company's website at www.djortho.com and clicking on the webcast link in the investor relations section. The webcast will be archived approximately three hours after the live event.
About dj Orthopedics, Inc.
dj Orthopedics is a global orthopedic sports medicine company focused on the design, manufacture and marketing of products and services that regenerate and rehabilitate soft tissue and bone after trauma, help protect against injury and treat osteoarthritis of the knee. Its broad range of over 600 rehabilitation products, many of which are based on proprietary technologies, includes rigid knee braces, soft goods, specialty and other complementary orthopedic products such as cold therapy and pain management systems. The Company's regeneration products consist of two bone growth stimulation devices,
the OL1000, approved by the FDA in 1994, which utilizes patented combined magnetic field technology to deliver a highly specific, low-energy signal for the non-invasive treatment of an established nonunion fracture acquired secondary to trauma, excluding vertebrae and all flat bones, and SpinaLogic®, a state-of-the-art device used as an adjunct to primary lumbar
spinal fusion surgery for one or two levels, approved by the FDA in late 1999. The Company's products provide solutions for orthopedic professionals and their patients throughout the patient's continuum of care. For more information, visit the Company's website at www.djortho.com .
SOURCE dj Orthopedics, Inc.
-0- 01/16/2004
/CONTACT: Investor/Media, Mark Francois, Director of Investor Relations
-760-734-4766, Mark.Francois[at]djoglobal[dot]com/
/Web site: http://www.djortho.com
(DJO)
CO: dj Orthopedics, Inc.
ST: California, New York
IN: MTC BIO HEA SPT
SU: TDS CCA
JA
-- LAF008 --
1317 01/16/2004 07:00 EST http://www.prnewswire.com
Company Investor/Media Contact:
DJO Incorporated
Mark Francois
Director of Corporate Communications & Investor Relations
760-734-4766
Mark.Francois[at]djoglobal[dot]com
